Spinal muscular atrophy: going beyond the motor neuron - PubMed (original) (raw)
Review
Spinal muscular atrophy: going beyond the motor neuron
Gillian Hamilton et al. Trends Mol Med. 2013 Jan.
Abstract
Spinal muscular atrophy (SMA) is a neuromuscular disease caused by abnormally low cellular levels of the ubiquitous protein SMN. Traditionally, reduced levels of SMN were thought to cause the selective death of lower motor neurons, leading to denervation and atrophy of skeletal muscles. However, numerous recent studies challenge the notion that SMA is solely a disease of lower motor neurons, indicating that SMA may actually be a multi-system disorder. There are several promising therapies for SMA, but effectively targeting treatment to all affected cells and tissues remains a major issue. Identifying and characterizing pathological changes that occur across all cell types and tissues affected by SMA is crucial for successfully developing new SMA therapeutics, and in this review we summarize recent developments in understanding the function of SMN in cells above and beyond motor neurons.
Copyright © 2012 Elsevier Ltd. All rights reserved.
Similar articles
- Stathmin, a microtubule-destabilizing protein, is dysregulated in spinal muscular atrophy.
Wen HL, Lin YT, Ting CH, Lin-Chao S, Li H, Hsieh-Li HM. Wen HL, et al. Hum Mol Genet. 2010 May 1;19(9):1766-78. doi: 10.1093/hmg/ddq058. Epub 2010 Feb 22. Hum Mol Genet. 2010. PMID: 20176735 - Tissue-specific models of spinal muscular atrophy confirm a critical role of SMN in motor neurons from embryonic to adult stages.
Laird AS, Mackovski N, Rinkwitz S, Becker TS, Giacomotto J. Laird AS, et al. Hum Mol Genet. 2016 May 1;25(9):1728-38. doi: 10.1093/hmg/ddw044. Epub 2016 Feb 16. Hum Mol Genet. 2016. PMID: 26908606 - A new model to study spinal muscular atrophy: neurite degeneration and cell death is counteracted by BCL-X(L) Overexpression in motoneurons.
Garcera A, Mincheva S, Gou-Fabregas M, Caraballo-Miralles V, Lladó J, Comella JX, Soler RM. Garcera A, et al. Neurobiol Dis. 2011 Jun;42(3):415-26. doi: 10.1016/j.nbd.2011.02.003. Epub 2011 Feb 16. Neurobiol Dis. 2011. PMID: 21333739 - Spinal Muscular Atrophy: More than a Disease of Motor Neurons?
Nash LA, Burns JK, Chardon JW, Kothary R, Parks RJ. Nash LA, et al. Curr Mol Med. 2016;16(9):779-792. doi: 10.2174/1566524016666161128113338. Curr Mol Med. 2016. PMID: 27894243 Review. - Spinal muscular atrophy: a deficiency in a ubiquitous protein; a motor neuron-specific disease.
Monani UR. Monani UR. Neuron. 2005 Dec 22;48(6):885-96. doi: 10.1016/j.neuron.2005.12.001. Neuron. 2005. PMID: 16364894 Review.
Cited by
- Molecular Mechanisms of Neurodegeneration in Spinal Muscular Atrophy.
Ahmad S, Bhatia K, Kannan A, Gangwani L. Ahmad S, et al. J Exp Neurosci. 2016 Mar 23;10:39-49. doi: 10.4137/JEN.S33122. eCollection 2016. J Exp Neurosci. 2016. PMID: 27042141 Free PMC article. Review. - Disease mechanisms and therapeutic approaches in spinal muscular atrophy.
Tisdale S, Pellizzoni L. Tisdale S, et al. J Neurosci. 2015 Jun 10;35(23):8691-700. doi: 10.1523/JNEUROSCI.0417-15.2015. J Neurosci. 2015. PMID: 26063904 Free PMC article. Review. - Patient-Reported Prevalence of Non-motor Symptoms Is Low in Adult Patients Suffering From 5q Spinal Muscular Atrophy.
Günther R, Wurster CD, Cordts I, Koch JC, Kamm C, Petzold D, Aust E, Deschauer M, Lingor P, Ludolph AC, Hermann A. Günther R, et al. Front Neurol. 2019 Nov 1;10:1098. doi: 10.3389/fneur.2019.01098. eCollection 2019. Front Neurol. 2019. PMID: 31736847 Free PMC article. - Long-Term _SMN_- and _Ncald_-ASO Combinatorial Therapy in SMA Mice and _NCALD_-ASO Treatment in hiPSC-Derived Motor Neurons Show Protective Effects.
Muiños-Bühl A, Rombo R, Ling KK, Zilio E, Rigo F, Bennett CF, Wirth B. Muiños-Bühl A, et al. Int J Mol Sci. 2023 Feb 20;24(4):4198. doi: 10.3390/ijms24044198. Int J Mol Sci. 2023. PMID: 36835624 Free PMC article. - Central synaptopathy is the most conserved feature of motor circuit pathology across spinal muscular atrophy mouse models.
Buettner JM, Sime Longang JK, Gerstner F, Apel KS, Blanco-Redondo B, Sowoidnich L, Janzen E, Langenhan T, Wirth B, Simon CM. Buettner JM, et al. iScience. 2021 Oct 30;24(11):103376. doi: 10.1016/j.isci.2021.103376. eCollection 2021 Nov 19. iScience. 2021. PMID: 34825141 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical